T1	condition 14 45	pegfilgrastim-induced bone pain
T2	No-of-participants 551 554	510
T3	intervention 594 602	naproxen
T4	control 633 640	placebo
T5	outcome-Measure 859 915	area under the curve (AUC) for pain for days 1 through 5
T6	outcome-Measure 975 1015	risk factors for the development of pain
T7	outcome-Measure 1020 1040	response to naproxen
T8	average-age 1065 1075	55.6 years
T9	outcome 1172 1176	Pain
T10	outcome 1225 1242	mean AUC for pain
T11	outcome 1335 1347	maximum pain
T12	outcome 1400 1422	overall pain incidence
T13	outcome 1458 1466	duration
T14	outcome 1506 1530	reduction in severe pain
